Botanix Receives Approval for Synthetic Cannabidiol Trial
Filed with ASX · · 2 pages · English
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings CallBotanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Export and Import Approvals for Clinical Studies Received
- Botanix Announces Filing of New Permetrex Product Patents
- Botanix Announces Expansion of Permetrex License
- Quarterly Cashflow Report
- Botanix Announces Positive Human Trial Data
Later from Botanix Pharmaceuticals
- Suspension from Official Quotation
- Reinstatement to official quotation
- Completion of the Tranche 1 Placement
- Botanix Commences First Clinical Study for BTX 1503
- Completion of Tranche 2 of Capital Raising Placement
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals